H1B Salary Data

Home › Employers › Selkirk Pharma, Inc.

Selkirk Pharma, Inc.: H-1B salaries and sponsorship

Selkirk Pharma, Inc. filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $126,316.

Applications (LCAs)3
Certified3
Employer addressSpokane, WA
H-1B dependent employerNo
Median offered salary$126,316
Middle half of salaries$119,474–$133,158
10th–90th percentile$115,369–$137,263

Does Selkirk Pharma, Inc. sponsor H-1B visas?

Selkirk Pharma, Inc. filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Jun 6, 2024. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Senior Computer System Validation Specialist2$112,632
Manager, Computer Systems Validation1$140,000

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20243$126,316

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Senior Computer System Validation Specialist$112,632
Level IV
Spokane, WAJun 6, 2024Jul 1, 2024Certified
Senior Computer System Validation Specialist$112,632
part-time · Level III
Spokane, WAMay 31, 2024Jun 17, 2024Certified
Manager, Computer Systems Validation$140,000
Level II
Spokane, WAFeb 9, 2024Jun 14, 2024Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).